Skip to content

Clinical trials

Nasopharyngeal Carcinoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nasopharyngeal Carcinoma Country / region: China Clear all

459 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20051
20063
20074
20085
20094
20106
20117
201212
20139
20149
201522
201623
201723
201828
201927
202035
202134
202255
202340
202445
202535
202626

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status179
Recruiting115
Completed80
Active, not recruiting39
Not yet recruiting28
Terminated13
Withdrawn3
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University172
Fudan University26
Zhejiang Cancer Hospital20
Jiangxi Provincial Cancer Hospital12
Fujian Cancer Hospital10
Ming-Yuan Chen10
Nanfang Hospital, Southern Medical University8
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University8
Eye & ENT Hospital of Fudan University7
Wei Jiang7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nasopharyngeal Carcinoma459
Nasopharyngeal Neoplasms30
Recurrence20
Neoplasm Metastasis17
Epstein-Barr Virus Infections10
Head and Neck Neoplasms9
Stomatitis8
Squamous Cell Carcinoma of Head and Neck7
Carcinoma, Non-Small-Cell Lung5
Carcinoma, Renal Cell4

Trials

Showing 1 to 25 of 459. Each trial links to its page on Pharma Observatory.

359 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.